APP and early-onset autosomal dominant Alzheimer disease: The particular Aβ oligomer profile generated in each line of APP transgenic mouse likely results from multiple factors, including genetic background, level of transgene expression, and Alzheimer’s disease-linked mutation(s) in the transgene that influence the Aβ42/Aβ40 ratio.